Intracranial Monitoring Tasks for Language Disorders
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how the brain processes language by studying people with epilepsy who are already undergoing brain monitoring. Participants will perform simple behavioral tasks during intracranial monitoring while doctors observe brain activity to learn more about speech comprehension. The trial seeks individuals with epilepsy who require brain monitoring on the left side of the brain and can follow directions and provide consent.
As an unphased study, this trial offers a unique opportunity to contribute to groundbreaking research on language processing in the brain.
Do I need to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that intracranial monitoring is safe for language disorder research?
Research has shown that performing behavioral tasks during brain monitoring is generally safe. Studies have found these activities to be non-invasive and free from serious side effects. Brain monitoring, a common procedure for diagnosing and treating epilepsy, further ensures safety. Overall, patients performing these tasks have not reported major problems, making the treatment manageable.12345
Why are researchers excited about this trial?
Researchers are excited about using behavioral tasks during intracranial monitoring for language disorders because it offers a unique method to understand how the brain processes language in real-time. Unlike other treatments that rely on external observations or brain imaging, this approach directly monitors brain activity in patients with pharmaco-resistant epilepsy. This direct monitoring can provide more precise insights into the language processing areas of the brain, potentially leading to more effective, personalized therapies for language disorders.
What evidence suggests that these behavioral tasks during intracranial monitoring are effective for language disorders?
This trial involves epileptic participants undergoing intracranial monitoring to study language disorders. Although this trial does not include speech and language therapy, research has shown that such therapies can help people with chronic aphasia regain language skills. These therapies can enhance abilities like speaking, reading, and writing. For example, a Cochrane review found that individuals who received language therapy performed better than those who did not. Additionally, intensive language therapy over a few weeks has proven effective in clinical settings. Overall, strong evidence supports the effectiveness of these therapies in helping people with language disorders recover their language abilities.678910
Are You a Good Fit for This Trial?
This trial is for adults aged 18-85 with language disorders or epilepsy who are already scheduled for intracranial monitoring of the left cerebral hemisphere. Participants must be able to follow test instructions and give informed consent.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intracranial Monitoring
Neural responses to language stimuli are collected from epileptic patients undergoing intracranial monitoring
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Behavioral tasks during intracranial monitoring
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor
Massachusetts Institute of Technology
Collaborator